Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries Limited a pharmaceutical company develops manufactures markets and distributes generic medicines specialty medicines and biopharmaceutical products in North America Europe Israel and internationally. The company offers sterile products hormones high-potency drugs and cytotoxic substances in various dosage forms including tablets capsules injectables inhalants liquids transdermal patches ointments and creams. It also manufactures and sells active pharmaceutical ingredients as well as provides contract manufacturing services; and operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies. In addition it focuses on the central nervous system (CNS) pain respiratory and oncology areas. The company's products portfolio in the CNS field comprises Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine in adults; and AUSTEDO for the treatment of neurodegenerative and movement disorders associated with Huntington's disease and tardive dyskinesia; respiratory therapeutic area includes ProAir RespiClick QVAR ProAir Digihaler AirDuo Digihaler ArmonAir Digihaler BRALTUS CINQAIR/CINQAERO DuoResp Spiromax and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease; and oncology therapeutic field consists of Bendeka Treanda Granix Trisenox Lonquex and Tevagrastim/Ratiograstim. Teva Pharmaceutical Industries Limited has a collaboration MedinCell for the development and commercialization of multiple long-acting injectable products a risperidone suspension for the treatment of patients with schizophrenia. The company was founded in 1901 and is headquartered in Tel Aviv Israel.